Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation - ScienceDirect
![PDF] Lipopolysaccharide Animal Models for Parkinson's Disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a63c762e0fa3c8d5b24bb90bbf75a3ae3fff0174/6-Figure1-1.png "PDF] Lipopolysaccharide Animal Models for Parkinson's Disease | Semantic Scholar")
PDF] Lipopolysaccharide Animal Models for Parkinson's Disease | Semantic Scholar
Parkinson's disease: a systemic inflammatory disease accompanied by bacterial inflammagens | bioRxiv
Frontiers | Review: The Role of Intestinal Dysbiosis in Parkinson's Disease
Frontiers | Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model
IJMS | Free Full-Text | Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models
The Synergy of Aging and LPS Exposure in a Mouse Model of Parkinson's Disease
The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease
PDF) Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson's Disease | Jadwiga Wardas - Academia.edu
Parkinson's disease: Are gut microbes involved? | American Journal of Physiology-Gastrointestinal and Liver Physiology
The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system | SpringerLink
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease | Semantic Scholar
The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson's Disease
IJMS | Free Full-Text | Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice
Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease | Journal of Neuroinflammation | Full Text
Frontiers | Genetic Imaging of Neuroinflammation in Parkinson's Disease: Recent Advancements
IJMS | Free Full-Text | Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson's Disease in Rats
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease | Acta Pharmacologica Sinica
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
PDF) Further characterisation of the LPS model of Parkinson's disease: A comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat. | Pádraig Mulcahy -
Protective effects of DL‑3‑n‑butylphthalide in the lipopolysaccharide‑induced mouse model of Parkinson's disease
Perillyl Alcohol Attenuates NLRP3 Inflammasome Activation and Rescues Dopaminergic Neurons in Experimental In Vitro and In Vivo Models of Parkinson's Disease | ACS Chemical Neuroscience
PDF) Lipopolysaccharide Animal Models for Parkinson's Disease
